Navigation Links
Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome
Date:10/22/2013

ANAHEIM, Calif., Oct. 22, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that it will commence a Phase 2 study to explore the efficacy and safety of H.P. Acthar® Gel (repository corticotropin injection) for Acute Respiratory Distress Syndrome (ARDS).  The Company's Investigational New Drug (IND) application for the study has been reviewed by the U.S. Food and Drug Administration (FDA) and is now active.  ARDS is an acute life-threatening lung condition that can result from pulmonary and non-pulmonary infections or a multitude of other serious conditions. Based on our understanding of its potential mechanism of action, Questcor believes that Acthar could have both steroid-independent and steroid-dependent protective effects in this condition.

The study will seek to enroll up to 210 patients in a 4-week randomized, placebo controlled trial designed to explore the efficacy and safety of several dosing regimens of Acthar in patients with moderate to severe ARDS.  The primary objective of the study will be to determine if Acthar increases the number of ventilator-free days during the 28-day treatment period. Secondary endpoints include whether Acthar therapy diminishes mortality, organ failure and the length of hospital or ICU stay.

"Despite advances in supportive care, there are no pharmacologic therapies that address acute respiratory distress syndrome, an urgent medical condition that results in mortality rates from 25 percent to over 40 percent of patients," said Dr. David Young, Questcor's Chief Scientific Officer. "While Acthar's exact mechanism of action is unknown, based on our understanding from scientific literature and nonclinical data, we believe Acthar may be beneficial in ARDS patients via its potential anti-inflammator
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
2. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
3. Questcor to Commence Phase 2 Study of Acthar for ALS
4. Questcor to Report Second Quarter Financial Results on July 30, 2013
5. Questcor to Initiate Pilot Commercialization Effort In Pulmonology for Symptomatic Sarcoidosis
6. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
7. Questcor Adds Angus C. Russell to Board of Directors
8. Questcor Reports First Quarter Financial Results
9. Questcor to Report First Quarter Results on April 30, 2013
10. Questcor Reports Fourth Quarter and Full Year 2012 Results
11. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), provided updates regarding the notice it received ... (the "Exchange") indicating that the Company was below certain ... in Sections 134 and 1101 of the NYSE MKT ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX ... providing health care services in China through the operations ... primary care hospitals and affiliated ambulatory clinics, today announced ... ended December 31, 2010. Presentation of ...
... American Association for Homecare strongly endorses bipartisan legislation to ... program for home medical equipment and services (durable medical ... Glenn Thompson (R-Pa.) and Jason Altmire (D-Pa.) on March ... Bidding Act."   Tyler Wilson, president ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 2Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 3Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 4Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 5Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 6Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 7Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 8Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 9Chindex International, Inc. Reports Financial Results for the Three and Nine Month Period Ended December 31, 2010 10Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 2Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare 'Competitive' Bidding Program for Homecare 3
(Date:7/30/2015)... ... ... Google recently announced that it will be disclosing any incidents involving its ... 8, 2015 article published by Nasdaq , the powerful tech company maintains that ... cars, which such industry players as Tesla CEO Elon Musk believe may very well ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... its monthly Biz Report, which takes a look at small, medium, and large ... and a business expert, conducted the business review and shared with viewers how ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a high-quality provider ... recently announced that the Centers for Medicare and Medicaid (CMS) have awarded its agency ... providers. 24/7 Care At Home’s agency is one of three top Orange County agencies ...
(Date:7/30/2015)... ... 2015 , ... The need for accessibility is never greater than when we ... as well as visiting friends and family during these critical moments, hospitals around the ... - powered by ChargeItSpot , a Philadelphia-based startup that recently secured a $4M ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... as the company and UCLA’s Jonsson Comprehensive Cancer Center (JCCC) mutually ... With the new collaboration, OncLive’s editorial and marketing groups will help spread the ...
Breaking Medicine News(10 mins):Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4
... Elected 2008 President of the HBA, FAIRFIELD, ... at its,helm, Elizabeth M. Mutisya, MD, and a ... (HBA) continues to,mark its 30th Anniversary with an ... furthering the advancement of women leaders in,healthcare worldwide. ...
... should only,approve the proposed merger of Highmark and ... competition in,Pennsylvania, Capital BlueCross President and CEO Anita ... Smith was asked by Committee Chairman Sen. Don ... the lens of the uniquely competitive,health- insurance landscape ...
... Crowell & Moring LLP is,pleased to announce the ... office as a member of the firm,s Antitrust and ... she helped found and co-chair,the firm,s Healthcare Industry Group. ... Trade Commission (FTC), where she investigated and,prosecuted mergers, joint ...
... Prescription and ... Over-The-Counter Medications, LOS ANGELES, Jan. 30 ... aches, pains and debilitating,arthritis. Most often, pain sufferers reach for ... and how to treat it safely, effectively,and more holistically. In ...
... CAMBRIDGE, England, January 30 The next generation ... of IT and different,expectations regarding healthcare than their ... by Cambridge, UK-based Wireless Healthcare,will increase the take ... being used by the elderly., In the ...
... Michigan Chamber of,Commerce today released the following statement by ... the Michigan Chamber, in response to,Governor Granholm,s call in ... to make it easier for personal injury lawyers to ... stressed the need to work cooperatively,to move Michigan forward, ...
Cached Medicine News:Health News:Healthcare Businesswomen's Association Announces 2008 Board of Directors 2Health News:Healthcare Businesswomen's Association Announces 2008 Board of Directors 3Health News:Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvania's Review of Proposed Highmark-IBC Merger 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 3Health News:Photos: Niavin Corporation Offers Pain Sufferers a New Way to Address Pain 2Health News:Increase in IT Skills Amongst the Elderly Will Boost Telecare Market 2
This extra long 180 ul pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
This tip's tight fit and MicroPoint design make it ideal for use with the Pipetman P-20. 10 L reference mark ensures consistent pipetting with low volumes....
... as both regular and filter tips. Sterilized ... more efficient sterilization and are delivered with ... of irradiation. Sterilized Diamond Tips are ready ... Diamond Tips are wrapped in medical device ...
Medicine Products: